Unichem Laboratories Balance Sheet Health
Financial Health criteria checks 5/6
Unichem Laboratories has a total shareholder equity of ₹24.0B and total debt of ₹2.7B, which brings its debt-to-equity ratio to 11.2%. Its total assets and total liabilities are ₹33.1B and ₹9.1B respectively. Unichem Laboratories's EBIT is ₹526.1M making its interest coverage ratio 3. It has cash and short-term investments of ₹2.0B.
Key information
11.2%
Debt to equity ratio
₹2.68b
Debt
| Interest coverage ratio | 3x |
| Cash | ₹1.98b |
| Equity | ₹24.01b |
| Total liabilities | ₹9.10b |
| Total assets | ₹33.11b |
Recent financial health updates
Is Unichem Laboratories (NSE:UNICHEMLAB) Using Debt Sensibly?
Feb 01
Does Unichem Laboratories (NSE:UNICHEMLAB) Have A Healthy Balance Sheet?
Sep 06Unichem Laboratories (NSE:UNICHEMLAB) Is Making Moderate Use Of Debt
Nov 27Is Unichem Laboratories (NSE:UNICHEMLAB) Weighed On By Its Debt Load?
Dec 10Is Unichem Laboratories (NSE:UNICHEMLAB) Using Too Much Debt?
Aug 26
Recent updates
Revenues Tell The Story For Unichem Laboratories Limited (NSE:UNICHEMLAB) As Its Stock Soars 26%
Nov 02It's A Story Of Risk Vs Reward With Unichem Laboratories Limited (NSE:UNICHEMLAB)
Sep 13Optimistic Investors Push Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares Up 26% But Growth Is Lacking
Feb 06Is Unichem Laboratories (NSE:UNICHEMLAB) Using Debt Sensibly?
Feb 01Does Unichem Laboratories (NSE:UNICHEMLAB) Have A Healthy Balance Sheet?
Sep 06Unichem Laboratories (NSE:UNICHEMLAB) Is Due To Pay A Dividend Of ₹4.00
Jul 30There's Reason For Concern Over Unichem Laboratories Limited's (NSE:UNICHEMLAB) Massive 28% Price Jump
Jul 23Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 15Unichem Laboratories (NSE:UNICHEMLAB) Will Pay A Dividend Of ₹4.00
Jul 01Unichem Laboratories (NSE:UNICHEMLAB) Is Making Moderate Use Of Debt
Nov 27Investors Shouldn't Be Too Comfortable With Unichem Laboratories' (NSE:UNICHEMLAB) Robust Earnings
Jun 05Should Unichem Laboratories Limited (NSE:UNICHEMLAB) Be Part Of Your Income Portfolio?
Mar 02Unichem Laboratories Limited's (NSE:UNICHEMLAB) Stock's Been Going Strong: Could Weak Financials Mean The Market Will Correct Its Share Price?
Feb 09Should You Take Comfort From Insider Transactions At Unichem Laboratories Limited (NSE:UNICHEMLAB)?
Jan 19Do Institutions Own Unichem Laboratories Limited (NSE:UNICHEMLAB) Shares?
Dec 29Is Unichem Laboratories (NSE:UNICHEMLAB) Weighed On By Its Debt Load?
Dec 10Key Things To Understand About Unichem Laboratories' (NSE:UNICHEMLAB) CEO Pay Cheque
Nov 23Did Unichem Laboratories' (NSE:UNICHEMLAB) Share Price Deserve to Gain 41%?
Nov 02Should You Buy Unichem Laboratories Limited (NSE:UNICHEMLAB) For Its 1.5% Dividend?
Oct 13How Much Are Unichem Laboratories Limited (NSE:UNICHEMLAB) Insiders Spending On Buying Shares?
Sep 16Is Unichem Laboratories (NSE:UNICHEMLAB) Using Too Much Debt?
Aug 26Is Unichem Laboratories Limited's (NSE:UNICHEMLAB) Shareholder Ownership Skewed Towards Insiders?
Aug 05Would Shareholders Who Purchased Unichem Laboratories'(NSE:UNICHEMLAB) Stock Three Years Be Happy With The Share price Today?
Jul 14Financial Position Analysis
Short Term Liabilities: UNICHEMLAB's short term assets (₹18.3B) exceed its short term liabilities (₹8.2B).
Long Term Liabilities: UNICHEMLAB's short term assets (₹18.3B) exceed its long term liabilities (₹907.1M).
Debt to Equity History and Analysis
Debt Level: UNICHEMLAB's net debt to equity ratio (2.9%) is considered satisfactory.
Reducing Debt: UNICHEMLAB's debt to equity ratio has increased from 7.3% to 11.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable UNICHEMLAB has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: UNICHEMLAB is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 33.6% per year.